The growth of Viagra and its effect on the drug landscape presents a complex question for investors. While the initial sales statistics were impressive, the exclusivity has ended, leading to a wave of off-brand alternatives that are reducing earnings. Furthermore, the market is facing issues related to aging trends and shifting healthcare polici… Read More